Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Afya (DE:1AY)
FRANKFURT:1AY
Holding DE:1AY?
Track your performance easily
1AY Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€13.60 - €19.80
Previous Close€14.8
Volume0.00
Average Volume (3M)N/A
Market Cap
€1.49B
Enterprise Value€1.87B
Total Cash (Recent Filing)R$553.03M
Total Debt (Recent Filing)R$2.83B
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Mar 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding89,949,353
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)0.37
Price to Sales (P/S)3.06
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€19.60Price Target Upside32.45% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Afya News
PremiumCompany Announcements
Afya Limited Reports Strong Q3 2024 Financial Growth
PremiumCompany Announcements
Afya Limited Reports Strong Q3 Financial Growth
PremiumCompany Announcements
Afya Limited Reports Strong Financial Growth
PremiumCompany Announcements
Afya Limited Expands Medical Seats in BrazilBulls Say, Bears Say
Bulls Say
Financial PerformanceAfya reported a strong quarter with a net income beating expectations by 24% at R$210mn, attributed to a lower effective tax rate and improving operational results.
Growth StrategyAfya is expected to support above-average growth of 12% until 2028, driven by inorganic expansion, approval of potential medical seats, and expansion in continuing education and medical practice solutions.
Market PositioningAfya's focus on the medicine segment, which has a superior cash flow profile, justifies a 50% premium to peers, highlighting its strong market positioning.
Bears Say
CompetitionNew medical seats approved by Mais Médicos III could bring additional competition for Afya's medical schools.
GrowthB2B in Medical Practice is growing 20% YTD, but its services are not yet recurring and the pace needs to be even higher to achieve the 2028 guidance.
RevenueTop-line pressure could arise due to higher competition in the medical segment.
---
1AY FAQ
What was Afya’s price range in the past 12 months?
Afya lowest stock price was €13.60 and its highest was €19.80 in the past 12 months.
What is Afya’s market cap?
Currently, no data Available
When is Afya’s upcoming earnings report date?
Afya’s upcoming earnings report date is Mar 28, 2025 which is in 134 days.
How were Afya’s earnings last quarter?
Currently, no data Available
Is Afya overvalued?
According to Wall Street analysts Afya’s price is currently Undervalued.
Does Afya pay dividends?
Afya does not currently pay dividends.
What is Afya’s EPS estimate?
Afya’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Afya have?
Afya has 46,390,125 shares outstanding.
What happened to Afya’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Afya?
Among the largest hedge funds holding Afya’s share is Dodge & Cox. It holds Afya’s shares valued at 515K.
---
Afya Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€19.60 (32.45% Upside)
€19.60 (32.45% Upside)
Blogger Sentiment
Bullish
DE:1AY Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.45%
12-Months-Change
Fundamentals
Return on Equity
15.54%
Trailing 12-Months
Asset Growth
-13.13%
Trailing 12-Months
Company Description
Afya
Afya Ltd. is a medical education group in Brazil. It delivers an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs and continuing medical education activities. The company operates through the following two segments: Education Services and Residency Preparatory & Specialization Programs. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences and other undergraduate programs. The Residency Preparatory & Specialization Programs segment provides residency preparatory courses and medical post-graduate specialization programs, delivering printed and digital content, an online medical education platform and practical medical training. Afya was founded on March 22, 2019 and is headquartered in Sao Paulo, Brazil.
---
1AY Company Deck
---
1AY Earnings Call
Q2 2024
0:00 / 0:00
---
1AY Stock 12 Month Forecast
Average Price Target
€19.60
▲(32.45% Upside)
Technical Analysis
Best Analysts Covering 1AY
1 Year
1 Year Success Rate
10/16 ratings generated profit
1 Year Average Return
+14.90%
reiterated a buy rating 16 days ago
Copying Fred Mendes's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +14.90% per trade.
---